HIV-1-Gag Conserved-Element DNA Vaccine (p24CE) Vaccine Study
Clinical trial NCT03560258 · COMPLETED
Trial details
- NCT number
- NCT03560258
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-26
- Primary completion
- 2021-02-10
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.